跳至主要内容
临床试验/NL-OMON35816
NL-OMON35816已完成不适用

A randomized double-blind placebo controlled trial to evaluate the value of a single bolus intravenous alfentanil in CT-colonography - Alfentanil in CT-colonography

Academisch Medisch Centrum0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 18 tot 85 years
  • Written informed consent
  • Scheduled for CT-colonography for symptoms or increased risk for colorectal cancer (including patients referred after incomplete colonoscopy)

排除标准

  • Hypotension (systolic blood pressure <90mmHg)
  • Bradycardia (heart rate < 50 bpm)
  • Severe COPD
  • Known allergy for alfentanil
  • Severe liver disease (defined as a Child-Pugh score >4)
  • Use of MAO-inhibitors or within two weeks before the CT-colonography procedure
  • Use of barbiturates, opiates or daily benzodiazepine use
  • Known increased intracranial pressure

研究者

相似试验